Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis
Bastiaan W. Haak, Hallie C. Prescott, W. Joost Wiersinga
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

Current gaps in sepsis immunology: new opportunities for translational research
Ignacio Rubio, Marcin F. Osuchowski, Manu Shankar‐Hari, et al.
The Lancet Infectious Diseases (2019) Vol. 19, Iss. 12, pp. e422-e436
Open Access | Times Cited: 274
Challenge to the Intestinal Mucosa During Sepsis
Felix Haussner, Shinjini Chakraborty, Rebecca Halbgebauer, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 170
Immunopathophysiology of human sepsis
W. Joost Wiersinga, Tom van der Poll
EBioMedicine (2022) Vol. 86, pp. 104363-104363
Open Access | Times Cited: 120
Microbiota-Immune Interaction in the Pathogenesis of Gut-Derived Infection
Chenyang Wang, Qiurong Li, Jianan Ren
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 135
Gut-Lung Crosstalk in Sepsis-Induced Acute Lung Injury
Xin Zhou, Youxia Liao
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 81
Gut microbial metabolite hyodeoxycholic acid targets the TLR4/MD2 complex to attenuate inflammation and protect against sepsis
Jiaxin Li, Yuqi Chen, Rui Li, et al.
Molecular Therapy (2023) Vol. 31, Iss. 4, pp. 1017-1032
Closed Access | Times Cited: 32
Treatment Advances in Sepsis and Septic Shock: Modulating Pro- and Anti-Inflammatory Mechanisms
A. M. Marques, Carla Torre, Rui Pinto, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 8, pp. 2892-2892
Open Access | Times Cited: 32
IRF3 function and immunological gaps in sepsis
Bristy Basak, Sachiko Akashi‐Takamura
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Anti-Pathogenic Functions of Non-Digestible Oligosaccharides In Vitro
Mostafa Asadpoor, Casper Peeters, Paul A. J. Henricks, et al.
Nutrients (2020) Vol. 12, Iss. 6, pp. 1789-1789
Open Access | Times Cited: 65
<p>Why targeting the microbiome is not so successful: can randomness overcome the adaptation that occurs following gut manipulation?</p>
Yaron Ilan
Clinical and Experimental Gastroenterology (2019) Vol. Volume 12, pp. 209-217
Open Access | Times Cited: 62
Mechanisms and immunomodulatory properties of pre- and probiotics
Vera B. M. Peters, Evita van de Steeg, Jolanda van Bilsen, et al.
Beneficial Microbes (2019) Vol. 10, Iss. 3, pp. 225-236
Closed Access | Times Cited: 57
Metabolomics and the Microbiome as Biomarkers in Sepsis
Jisoo Lee, Debasree Banerjee
Critical Care Clinics (2019) Vol. 36, Iss. 1, pp. 105-113
Closed Access | Times Cited: 57
Tetracycline Antibiotics Induce Host-Dependent Disease Tolerance to Infection
Henrique G. Colaço, André Barros, Ana Neves‐Costa, et al.
Immunity (2020) Vol. 54, Iss. 1, pp. 53-67.e7
Open Access | Times Cited: 54
Respiratory microbiome in mechanically ventilated patients: a narrative review
Mélanie Fromentin, Jean-Damien Ricard, Damien Roux
Intensive Care Medicine (2021) Vol. 47, Iss. 3, pp. 292-306
Open Access | Times Cited: 53
Fecal Microbiota Transplantation Protects the Intestinal Mucosal Barrier by Reconstructing the Gut Microbiota in a Murine Model of Sepsis
Xiaowei Gai, Huawei Wang, Yaqing Li, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 50
Gut microbiota and sepsis: from pathogenesis to novel treatments
Robert F. J. Kullberg, W. Joost Wiersinga, Bastiaan W. Haak
Current Opinion in Gastroenterology (2021) Vol. 37, Iss. 6, pp. 578-585
Open Access | Times Cited: 47
The role of bacterial translocation in sepsis: a new target for therapy
Assaf Potruch, Asaf Schwartz, Yaron Ilan
Therapeutic Advances in Gastroenterology (2022) Vol. 15
Open Access | Times Cited: 28
Lactobacillus rhamnosus GG Promotes Recovery of the Colon Barrier in Septic Mice through Accelerating ISCs Regeneration
Lufang Chen, Shumin Li, Chunting Peng, et al.
Nutrients (2023) Vol. 15, Iss. 3, pp. 672-672
Open Access | Times Cited: 21
Gut microbe-derived milnacipran enhances tolerance to gut ischemia/reperfusion injury
Fan Deng, Jingjuan Hu, Ze‐Bin Lin, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 3, pp. 100979-100979
Open Access | Times Cited: 21
Gut microbiota and sepsis: bidirectional Mendelian study and mediation analysis
Zhi Zhang, Lin Cheng, Ning Dong
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
Nobiletin protects against ferroptosis to alleviate sepsis-associated acute liver injury by modulating the gut microbiota
Weiwei Huang, Hui Chen, Qi He, et al.
Food & Function (2023) Vol. 14, Iss. 16, pp. 7692-7704
Open Access | Times Cited: 19
Nutritional and metabolic modulation of inflammation in critically ill patients: a narrative review of rationale, evidence and grey areas
Anne‐Françoise Rousseau, Robert G. Martindale
Annals of Intensive Care (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Adipose-derived mesenchymal stem cells attenuate acute lung injury and improve the gut microbiota in septic rats
Junyi Sun, Xianfei Ding, Shaohua Liu, et al.
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 46
Consolidation of Clinical Microbiology Laboratories and Introduction of Transformative Technologies
Olivier Vandenberg, G. Durand, Marie Hallin, et al.
Clinical Microbiology Reviews (2020) Vol. 33, Iss. 2
Open Access | Times Cited: 43
Early and sustained Lactobacillus plantarum probiotic therapy in critical illness: the randomised, placebo-controlled, restoration of gut microflora in critical illness trial (ROCIT)
Edward Litton, Matt Anstey, David Broadhurst, et al.
Intensive Care Medicine (2021) Vol. 47, Iss. 3, pp. 307-315
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top